TURATO, CRISTIAN
 Distribuzione geografica
Continente #
NA - Nord America 5.402
EU - Europa 658
AS - Asia 521
SA - Sud America 9
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 6.592
Nazione #
US - Stati Uniti d'America 5.399
CN - Cina 489
IT - Italia 190
FI - Finlandia 141
SE - Svezia 139
DE - Germania 80
GB - Regno Unito 43
IN - India 25
UA - Ucraina 24
IE - Irlanda 16
FR - Francia 12
BR - Brasile 8
NL - Olanda 5
BG - Bulgaria 3
CA - Canada 3
JP - Giappone 3
HK - Hong Kong 2
AU - Australia 1
BD - Bangladesh 1
BE - Belgio 1
ES - Italia 1
EU - Europa 1
KR - Corea 1
PL - Polonia 1
PT - Portogallo 1
PY - Paraguay 1
RO - Romania 1
Totale 6.592
Città #
Fairfield 864
Woodbridge 594
Chandler 464
Ann Arbor 439
Houston 399
Ashburn 362
Wilmington 346
Seattle 293
Cambridge 277
Jacksonville 257
Princeton 108
San Diego 97
Medford 96
Nanjing 86
Des Moines 82
Padova 77
Dearborn 69
Beijing 62
Helsinki 56
Roxbury 55
Boardman 49
Guangzhou 49
Changsha 33
Shenyang 30
Jinan 27
Nanchang 23
Hebei 22
Jiaxing 19
Kunming 19
Hefei 17
Dublin 16
Pune 16
Norwalk 14
Zhengzhou 12
London 11
New York 9
Shanghai 9
Ningbo 8
Falls Church 7
Tianjin 7
Cagliari 6
Haikou 6
Milan 6
Petrópolis 6
Washington 6
Kharkiv 5
Los Angeles 5
Ogden 5
Rockville 5
Rome 5
Baotou 4
Paris 4
Pesaro 4
Phoenix 4
Bologna 3
Cologno Monzese 3
Detroit 3
Hangzhou 3
Hounslow 3
Lanzhou 3
Redwood City 3
Sofia 3
Borås 2
Campodarsego 2
Celico 2
Changchun 2
Florence 2
Fuzhou 2
Gubbio 2
Huzhou 2
Indiana 2
Legnaro 2
Moncalieri 2
Niterói 2
Pavia 2
Pignone 2
Prescot 2
Reggio Nell'emilia 2
Southwark 2
Tappahannock 2
Tokyo 2
Travaco Siccomario 2
Trento 2
Turin 2
Urbino 2
Vicenza 2
Vigevano 2
Villa Del Conte 2
Wuhan 2
Acton 1
Andover 1
Araihazar 1
Ariano Irpino 1
Asunción 1
Bacoli 1
Bergamo 1
Bisceglie 1
Brussels 1
Canberra 1
Central 1
Totale 5.640
Nome #
Binding and Uptake into Human Hepatocellular Carcinoma Cells of Peptide-Functionalized Gold Nanoparticles 178
PreS1 peptide-functionalized gold nanostructures with SERRS tags for efficient liver cancer cell targeting 172
Increased Th1 immune response in SERPINB3 transgenic mice during acute liver failure 146
SCCA1 is associated to poor prognosis in esophageal cancer through immune surveillance impairment and reduced chemosensitivity 145
Increased myoendothelial gap junctions mediate the enhanced response to epoxyeicosatrienoic acid and acetylcholine in mesenteric arterial vessels of cirrhotic rats. 145
Correction: Corrigendum: SERPINB3 is associated with longer survival in transgenic mice 136
High-flow nasal cannula oxygen therapy to treat acute respiratory failure in patients with acute exacerbation of idiopathic pulmonary fibrosis 125
New molecular targets for functionalized nanosized drug delivery systems in personalized therapy for hepatocellular carcinoma 118
Inhibition of Epoxyeicosatrienoic Acid Production in Rats With Cirrhosis Has Beneficial Effects on Portal Hypertension by Reducing Splanchnic Vasodilation 117
MiR-122 Targets SerpinB3 and Is Involved in Sorafenib Resistance in Hepatocellular Carcinoma 110
SERPINB3 expression on B-cell surface in autoimmune diseases and hepatitis C virus-related chronic liver infection 109
SERPINB3 induces epithelial-mesenchymal transition. 109
SerpinB3 and Yap Interplay Increases Myc Oncogenic Activity 104
SERPINB3 expression on B-cell surface in autoimmune diseases and hepatitis C virus-related chronic liver infection 102
Over-expression of SERPINB3 in hepatoblastoma: A possible insight into the genesis of this tumour? 101
Role of squamous cell carcinoma antigen-1 on liver cells after partial hepatectomy in transgenic mice. 100
Effect of a passive exhalation port on tracheostomy ventilation in amyotrophic lateral sclerosis patients: A randomized controlled trial 99
Spontaneous pneumomediastinum complicating severe acute asthma exacerbation in adult patients 97
Changes in gene expression of cytochrome P-450 in liver, kidney and aorta of cirrhotic rats. 96
SERPINB3 INDUCES EPITHELIAL MESENCHYMAL TRANSITION 95
Pirfenidone improves the survival of patients with idiopathic pulmonary fibrosis hospitalized for acute exacerbation 95
Squamous cell carcinoma antigen-1 (SERPINB3) polymorphism in chronic liver disease 91
Exogenous Administration of SERPINB3 Inhibits Cell Reprogramming 91
Hepatic progenitor cells express SerpinB3 91
Role of microglial activation via SERPINB3 in experimental acute hepatic encephalopathy 91
The molecular signature of impaired diabetic wound healing identifies serpinB3 as a healing biomarker. 88
SerpinB3 induces dipeptidyl-peptidase IV/CD26 expression and its metabolic effects in hepatocellular carcinoma 87
Hypoxia up-regulates SERPINB3 through HIF-2α in human liver cancer cells. 86
SERPINB3 protects from oxidative damage by chemotherapeutics through inhibition of mitochondrial respiratory complex I 82
SERPINB3 is associated with TGF-β1 and cytoplasmic β-catenin expression in hepatocellular carcinomas with poor prognosis 79
High-flow nasal cannula oxygen therapy to treat patients with hypoxemic acute respiratory failure consequent to SARS-CoV-2 infection 78
Hepatic progenitor cells overexpress SERPINB3 in a mouse model of fulminant hepatitis 77
Cellule progenitrici epatiche esprimono SERPINB3b in un modello murino di epatite fulminante 76
SerpinB3 promotes pro-fibrogenic responses in activated hepatic stellate cells 75
SERPINB3 (serpin peptidase inhibitor, clade B (ovalbumin), member 3) 74
IgM-linked SerpinB3 and SerpinB4 in Sera of Patients with Chronic Liver Disease 73
Liver pro-oncogenic potential of SERPINB3. 73
SERPINB3 protects from oxidative damage by chemotherapeutics through inhibition of mitochondrial respiratory complex I. 71
Serpinb3 is overexpressed in the liver in presence of iron overload 68
HEPATIC PROGENITOR CELLS OVEREXPRESS SERPINB3 IN A MOUSE MODEL OF FULMINANT HEPATITIS 68
Modulazione dei livelli di IL-6 nella rigenerazione epatica da parte di SERPINB3 ed estrogeni. Analisi in un modello di topo transgenico 66
SERPINB3 INDUCES EPITHELIAL MESENCHYMAL TRANSITION 66
Implicazioni biologiche di SerpinB3 nella fibrosi epatica e nell'epatocarcinoma 66
Hepatic progenitor cells express SerpinB3. 64
SERPIN-B3 induces HIF2α nuclear translocation in hepatic cancer cells: a paracrine loop able to affect cancer cell behaviour 63
Increased antiprotease activity of the SerpinB3 polymorphic variant SCCA-PD 62
MicroRNAs and SerpinB3 in hepatocellular carcinoma. 62
Non-Invasive Ventilation for Acute Respiratory Failure in Duchenne Muscular Dystrophy Patients 62
SERPINB3 is associated with longer survival in transgenic mice. 61
Overexpression of SERPINB3 in hepatic progenitor cells in a mouse model of acute liver injury 59
DILAYED SYSTEMIC LUPUS ERYTHEMATOSUS SYMPTOMS AND INCREASED SURVIVAL BY SERPINB3 IN LUPUS-PRONE MICE 58
SERPINB3 modulates TGF-beta expression in chronic liver disease. 57
HPYPOXYA UP-REGULATES SERPINB3 IN HEPATIC CANCER CELLS: A HIF-2a ASSOCIATED EVENT RELATED TO INVASIVENESS AND EPITHELIAL TO MESENCHYMAL TRANSITION 57
Nintedanib Treatment for Idiopathic Pulmonary Fibrosis Patients Who Have Been Switched from Pirfenidone Therapy: A Retrospective Case Series Study 57
Sex dependent IL-6 deregulation by SERPINB3 in a transgenic mouse model 55
HYPOXIA UP-REGULATES SERPINB3 IN HEPG2 CELLS: A REDOX SENSITIVE EVENT RELATED TOEPITHELIAL TO MESENCHYMAL TRANSITIONAND INVASIVENESS 53
RUOLO DI SERPINB3 ELLA PROGRESSIONE DELLA MALATTIA EPATICA 53
Over-expression of SERPINB3 in hepatoblastoma: A possible insight into the genesis of this tumor? 52
RUOLO DI SERPINB3 NELLA PROGRESSIONE DELLA MALATTIA EPATICA 50
HFE, TGF-BETA1 AND SQUAMOUS CELL CARCNOMA ANTIGEN-1 POLYMORPHISMS AND LIVER DISEASE STAGE IN CHRONIC HCV INFECTION 48
CARATTERIZZAZIONE BIOLOGICA E FUNZIONE DELLA NUOVA ISOFORMA SCCA-PD 46
SERPIN-B3 as a pro-fibrogenic mediator contributing to chronic liver disease progression 46
SEX DEPENDENT IL-6 DEREGULATION BY SERPINB3 IN A TRANSGENIC MOUSE MODEL 45
CHARACTERIZATION OF SCCA-1(SERPINB3) ISOFORMS IN HEPATOCELLULAR CARCINOMA 45
SERPINB3 up-regulation in hepatic cancer cells: a critical HIF-2alfa and redox dependent event in liver carcinogenesis. 45
OVEREXPRESSION OF SERPINB3 IN HEPATIC PROGENITOR CELLS IN A MOUSE MODEL OF ACUTE LIVER INJURY 44
MODULAZIONE DI P53 E DELLE SUE VIE DI SEGNALE DA PARTE DI SERPINB3 44
SERPINB3 è associata a una maggior sopravvivenza in un modello di topo transgenico. 43
POLIMORFISMO DI SCCA (SQUAMOUS CELL CARCINOMA ANTIGEN) E PROGRESSIONE DELLA MALATTIA EPATICA NELL’INFEZIOE HCV 43
LRP-1 BINDS SERPINB3 AND MEDIATES ITS MIGRATORY ACTIVITY 43
MODULATION OF P35 SIGNALING BY SERPINB3 UNDER GENOTOXIC CONDITIONS 42
Prone Positioning Is Safe and May Reduce the Rate of Intubation in Selected COVID-19 Patients Receiving High-Flow Nasal Oxygen Therapy 42
PRO-ONCOGENIC EFFECT OF SQUAMOUS CELL CARCINOMA ANTIGEN VIA WNT/BETA-CATENIN SIGNALING 40
CELLULE PROGENITRICI EPATICHE ESPRIMONO SERPINB3 IN UN MODELLO MURINO DI EPATITE FULMINANTE 38
ROLE OF MICROGLIAL ACTIVATION VIA SERPINB3 IN EXPERIMENTAL ACUTE HEPATIC ENCEPHALOPATY 38
DETERMINAZIONE DELL’IMMUNOCOMPLESSO VEGF-IgM NELL’ EPATOCARCINOMA 38
SERPINB3 DOWNREGULATES THE PROAPOPTOTIC P66SHC PROTEIN IN HUMAN HEPATOMA CELLS 38
SERPINB3 PROMUOVE L’INVASIVITA’ CELLULARE 38
LEADING ROLE OF SERPINB3 IN MOLECULAR SIGNATURES OF WORSE PROGNOSIS IN HEPATOCELLULAR CARCINOMA 38
ULTRAFINE GOLD NANOPARTICLES CONJUGATED WITH PRES1 PEPTIDE OF HEPATITIS B VIRUS ENVELOPE PROTEIN TARGETING HEPATOMA CELLS 35
ULTRAFINE GOLD NANOPARTICLES CONJUGATED WITH PRES1 PEPTIDE OF HEPATITIS B VIRUS ENVELOPE PROTEIN TARGETING HEPATOMA CELLS 34
SERPINB3 AND TGF-BETA1 CORRELATION IN CHRONIC LIVER DISEASE OF VIRAL ETIOLOGY 32
ESPRESSIONE DI TGF-b1 NELLA MALATTIA EPATICA EVOLUTIVA 32
ESPRESSIONE DI TGF-b1 NELLA MALATTIA EPATICA EVOLUTIVA 32
SERPINB3 IS ASSOCIATED TO LONGER SERVIVAL IN MALE TRANSGENIC MICE 31
HIGH BRAIN EXPRESSION OF SQUAMOUS CELL CARCINOMA ANTIGEN ENHANCES BRAIN INJURY IN A TRANSGENIC MOUSE MODEL OF ACUTE LIVER FAILURE: A PILOT STUDY 29
SERPINB3 INCREASES RESISTANCE TO CISPLATIN-INDUCED CELL DEATH IN HEPATOMA CELLS THROUGH INHIBITION OF THE PERMEABILITY TRANSITON PORE 29
LRP-1 BINDS SERPINB3 AND MEDIATES ITS MIGRATORY ACTIVITY 29
SERPINB3 AND TGF-BETA IN CHRONIC LIVER DISEASE 29
Caratterizzazione biologica e funzionale della nuova isoforma SCCA-PD 28
ONCOSTATIN M IS OVEREXPRESSED IN HEPATOCELLULAR CARCINOMA AND CAN INDUCE EPITHELIAL TO MESENCHYMAL TRANSITION AND INCREASED INVASIVENESS IN HEPATIC CANCER CELLS BY TWO DISTINCT MECHANISMS 28
MODULAZIONE DEI LIVELLI DI IL-6 NELLA RIGENERAZIONE EPATICA DA PARTE DI SERPINB3 ED ESTROGENI. ANALISI IN UN MODELLO DI TOPO TRANSGENICO 28
SerpinB3 drives molecular signatures of worse prognosis and is associated with tumor recurrence in hepatocellular carcinoma 27
SERPINB3 AND TGF-BETA1 CORRELATION IN CHRONIC LIVER DISEASE 26
SERPINB3 IS OVEREXPRESSED IN HEPATOBLASTOMA AND CORRELATES WITH MYC SIGNALING AND ANATOMIC TUMOR INVASION 26
SERPINB3 UP-REGULATION BY HYPOXIA IN HEPG2 CELLS : A HIF-2ALPHA AND REDOX SENSITIVE EVENT RELATED TO INVASIVENESS AND EPITHELIAL TO MESENCHYMAL TRANSITION 25
SERPINB3 IS ASSOCIATED TO LONGHER SURVIVAL IN MALE TRANSGENIC MICE 25
ONCOSTATIN M, OVEREXPRESSED IN HEPATOCELLULAR CARCINOMA, UP-REGULATES SERPIN-B3 EXPRESSION IN HEPATIC CANCER CELLS 23
SERPINB3 AS A PRO-INFLAMMATORY MEDIATOR IN THE PROGRESSION OF EXPERIMENTAL NON-ALCOHOLIC FATTY LIVER DISEASE. 22
P66SHC EXPRESSION PROTEIN IS DOWNREGULATED BY SERPINB3 IN HUMAN HEPATOMA CELLS 21
Totale 6.576
Categoria #
all - tutte 20.989
article - articoli 16.600
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.589


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019374 0 0 0 0 0 0 0 0 0 0 179 195
2019/20201.680 233 61 33 210 152 127 199 178 162 188 72 65
2020/2021970 51 53 36 44 21 83 28 61 158 244 128 63
2021/20221.097 27 137 141 98 33 68 44 128 37 32 102 250
2022/20231.012 191 93 42 97 173 157 1 75 125 2 43 13
2023/2024390 28 69 63 50 26 70 35 14 17 18 0 0
Totale 6.633